These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33774219)

  • 1. Hypercoagulability Testing and Hypercoagulable Disorders in Young Central Retinal Vein Occlusion Patients.
    Tauqeer Z; Bracha P; McGeehan B; VanderBeek BL
    Ophthalmol Retina; 2022 Jan; 6(1):37-42. PubMed ID: 33774219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longitudinal analysis of risk factors associated with central retinal vein occlusion.
    Stem MS; Talwar N; Comer GM; Stein JD
    Ophthalmology; 2013 Feb; 120(2):362-70. PubMed ID: 23177364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LABORATORY EVALUATION OF HYPERCOAGULABLE STATES IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION WHO ARE LESS THAN 56 YEARS OF AGE.
    Liu Q; Lahey JM; Karlen R; Stewart JM
    Retina; 2018 Jun; 38(6):1175-1179. PubMed ID: 28613222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age.
    Lahey JM; Tunç M; Kearney J; Modlinski B; Koo H; Johnson RN; Tanaka S
    Ophthalmology; 2002 Jan; 109(1):126-31. PubMed ID: 11772591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for central retinal vein occlusion in young adults.
    Chen TY; Uppuluri A; Zarbin MA; Bhagat N
    Eur J Ophthalmol; 2021 Sep; 31(5):2546-2555. PubMed ID: 33008264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct medical costs and resource use for treating central and branch retinal vein occlusion in commercially insured working-age and Medicare populations.
    Suñer IJ; Margolis J; Ruiz K; Tran I; Lee P
    Retina; 2014 Nov; 34(11):2250-8. PubMed ID: 25046390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resource use and costs of branch and central retinal vein occlusion in the elderly.
    Fekrat S; Shea AM; Hammill BG; Nguyen H; Kowalski JW; Schulman KA; Curtis LH
    Curr Med Res Opin; 2010 Jan; 26(1):223-30. PubMed ID: 19921963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerotic and thrombophilic risk factors in patients with recurrent central retinal vein occlusion.
    Sodi A; Giambene B; Marcucci R; Sofi F; Bolli P; Abbate R; Prisco D; Menchini U
    Eur J Ophthalmol; 2008; 18(2):233-8. PubMed ID: 18320516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central retinal vein occlusion risk profile: a case-control study.
    Shahsuvaryan ML; Melkonyan AK
    Eur J Ophthalmol; 2003 Jun; 13(5):445-52. PubMed ID: 12841567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of coagulopathies and fibrinolytic abnormalities in central retinal vein occlusion in patients under 60 years of age].
    Tea S; Barrali M; Racadot E; Delbosc B
    J Fr Ophtalmol; 2013 Jan; 36(1):5-11. PubMed ID: 23238070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial thrombophilia and retinal vein occlusion.
    Backhouse O; Parapia L; Mahomed I; Lee D
    Eye (Lond); 2000 Feb; 14 ( Pt 1)():13-7. PubMed ID: 10755093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of systemic conditions at diagnosis between central retinal vein occlusion and branch retinal vein occlusion.
    Cho BJ; Bae SH; Park SM; Shin MC; Park IW; Kim HK; Kwon S
    PLoS One; 2019; 14(8):e0220880. PubMed ID: 31393915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.
    Glueck CJ; Ping Wang ; Hutchins R; Petersen MR; Golnik K
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):286-94. PubMed ID: 18160589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion.
    Sodi A; Giambene B; Marcucci R; Sofi F; Fedi S; Abbate R; Prisco D; Menchini U
    Retina; 2011 Apr; 31(4):724-9. PubMed ID: 21178660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CALRETICULIN MUTATION ASSOCIATED WITH BILATERAL CENTRAL RETINAL VEIN OCCLUSION IN A YOUNG WOMAN.
    Kabanovski A; Donaldson L; Koushan K; Margolin E
    Retin Cases Brief Rep; 2023 Jul; 17(4):389-391. PubMed ID: 34652304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercoagulability predicts worse outcomes in young patients undergoing lower extremity revascularization.
    Torrealba JI; Osman M; Kelso R
    J Vasc Surg; 2019 Jul; 70(1):175-180. PubMed ID: 30583891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombophilia as a risk factor for central retinal vein occlusion].
    Undas A; Kubicka-Trzaska A
    Klin Oczna; 2003; 105(3-4):221-4. PubMed ID: 14552191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrospective case analysis of ophthalmological and systemic risk factors in patients with retinal vascular occlusion].
    Klatt C; Purtskhvanidze K; Hasselbach H; Treumer F; Hillenkamp J; Roider J
    Ophthalmologe; 2010 May; 107(5):446-51. PubMed ID: 19756639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion.
    Hayreh SS; Zimmerman MB; Beri M; Podhajsky P
    Ophthalmology; 2004 Jan; 111(1):133-41. PubMed ID: 14711725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic thrombophilia in patients with retinal vascular occlusion.
    Greiner K; Peetz D; Winkgen A; Prellwitz W; Pfeiffer N; Hafner G
    Int Ophthalmol; 1999; 23(3):155-60. PubMed ID: 11456253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.